Search - tctmd.com

Displaying 981 - 1000 of 3780

Sort: Relevancy | Date

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

News Daily News

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

June 08, 2020

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

News Daily News

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

June 04, 2020

Carotid Endarterectomy Little Help in Asymptomatic Patients: VA Study

News Daily News

Carotid Endarterectomy Little Help in Asymptomatic Patients: VA Study

June 04, 2020

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

News Daily News

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

June 03, 2020

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

News Daily News

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

Michael O'Riordan

June 01, 2020

Complete Revascularization in STEMI Seems to Cut CV Mortality: Meta-analysis

News Daily News

Complete Revascularization in STEMI Seems to Cut CV Mortality: Meta-analysis

May 27, 2020

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

News Daily News

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

May 22, 2020

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Presentation SCAI 2020

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Presenter: Benjamin E. Peterson

May 21, 2020

FORZA: Randomized Trial of Fractional Flow Reserve vs Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses

Podcast TCTMD Talking Points

FORZA: Randomized Trial of Fractional Flow Reserve vs Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses

May 20, 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

News Conference News SCAI 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

May 15, 2020

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

May 08, 2020

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

News Daily News

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

April 29, 2020

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

April 29, 2020

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

News Daily News

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Michael O'Riordan

April 21, 2020

CABG Over PCI for Severe HFrEF Patients With Complex CAD: Observational Data

News Daily News

CABG Over PCI for Severe HFrEF Patients With Complex CAD: Observational Data

April 09, 2020

Aspirin Okay for Up to 30 Days

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

April 03, 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

April 02, 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

April 02, 2020

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

News Conference News ACC 2020

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Michael O'Riordan

March 30, 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

News Conference News ACC 2020

ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up

March 30, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.